Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

BARBARA K BURTON

Allopathic & Osteopathic Physicians Medical Genetics Clinical Genetics (M.D.)

NPI
1699743088
CMS profile
31005
Location
CHICAGO, IL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$84,919.17

69 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

By paying entity

PY2020 · entire year · sorted by reported total

Paying entityAmountRecords
BioMarin Pharmaceutical Inc. $40,524.44 40
Takeda Pharmaceuticals U.S.A., Inc. $21,242.01 14
GENZYME CORPORATION $7,452.72 10
Horizon Therapeutics plc $6,500.00 2
Ultragenyx Pharmaceutical Inc. $6,400.00 2
Alexion Pharmaceuticals, Inc. $2,800.00 1

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

69 matching records · $84,919.17 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 69 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 69.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Takeda Pharmaceuticals U.S.A., Inc. $1,150.0012/21/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747140081 CMS
BioMarin Pharmaceutical Inc. $750.0012/18/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747584869 CMS
BioMarin Pharmaceutical Inc. $300.0012/11/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026832209039 CMS
BioMarin Pharmaceutical Inc. $8,300.0011/18/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747584749 CMS
BioMarin Pharmaceutical Inc. $1,750.0011/13/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747585353 CMS
BioMarin Pharmaceutical Inc. $53.0911/13/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747585357 CMS
Takeda Pharmaceuticals U.S.A., Inc. $500.0011/12/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747140077 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,400.0011/12/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747140079 CMS
BioMarin Pharmaceutical Inc. $2,000.0011/11/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747584676 CMS
BioMarin Pharmaceutical Inc. $2,000.0010/26/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747584607 CMS
Takeda Pharmaceuticals U.S.A., Inc. $400.0010/26/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747140075 CMS
BioMarin Pharmaceutical Inc. $1,000.0010/19/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747584349 CMS
BioMarin Pharmaceutical Inc. $750.0010/15/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747584345 CMS
GENZYME CORPORATION $1,684.0010/09/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026744101473 CMS
BioMarin Pharmaceutical Inc. $750.0009/30/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747584335 CMS
Horizon Therapeutics plc $4,400.0009/21/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026721382029 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,300.0009/09/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747140073 CMS
Takeda Pharmaceuticals U.S.A., Inc. $460.0008/31/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747140071 CMS
Ultragenyx Pharmaceutical Inc. $3,200.0008/19/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026723163963 CMS
BioMarin Pharmaceutical Inc. $750.0008/18/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747584217 CMS
GENZYME CORPORATION $350.0008/14/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026744101413 CMS
GENZYME CORPORATION $300.0008/12/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026744101425 CMS
BioMarin Pharmaceutical Inc. $750.0008/06/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747584167 CMS
Takeda Pharmaceuticals U.S.A., Inc. $400.0008/03/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747140069 CMS
BioMarin Pharmaceutical Inc. $27.9607/02/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747582681 CMS
BioMarin Pharmaceutical Inc. $2,000.0007/02/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747583871 CMS
BioMarin Pharmaceutical Inc. $34.9607/02/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747585341 CMS
BioMarin Pharmaceutical Inc. $130.0007/02/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747585345 CMS
Alexion Pharmaceuticals, Inc. $2,800.0006/16/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026726627409 CMS
BioMarin Pharmaceutical Inc. $750.0006/16/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747584025 CMS
Ultragenyx Pharmaceutical Inc. $3,200.0006/15/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026723163961 CMS
Takeda Pharmaceuticals U.S.A., Inc. $3,500.0006/09/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747140067 CMS
Horizon Therapeutics plc $2,100.0006/05/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026721382027 CMS
BioMarin Pharmaceutical Inc. $1,000.0005/21/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747584711 CMS
BioMarin Pharmaceutical Inc. $750.0005/09/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747583301 CMS
BioMarin Pharmaceutical Inc. $750.0005/02/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747583905 CMS
BioMarin Pharmaceutical Inc. $1,500.0004/22/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747584783 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,625.0004/15/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747140065 CMS
BioMarin Pharmaceutical Inc. $125.0004/14/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026832209049 CMS
BioMarin Pharmaceutical Inc. $750.0004/13/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747583933 CMS
Takeda Pharmaceuticals U.S.A., Inc. $125.0004/07/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747140061 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,625.0004/07/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747140063 CMS
BioMarin Pharmaceutical Inc. $3,450.0003/31/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747583183 CMS
Takeda Pharmaceuticals U.S.A., Inc. $800.0003/16/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747140059 CMS
BioMarin Pharmaceutical Inc. $2,664.8103/06/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747583039 CMS
Takeda Pharmaceuticals U.S.A., Inc. $57.0102/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747140057 CMS
BioMarin Pharmaceutical Inc. $17.6402/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747583085 CMS
GENZYME CORPORATION $237.4802/10/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026744101353 CMS
GENZYME CORPORATION $44.3902/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026744101355 CMS
GENZYME CORPORATION $17.1602/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026744101357 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $190,342.26 267
PY2020 $84,919.17 69
PY2021 $63,232.52 45
PY2022 $105,239.90 91
PY2023 $99,255.26 146
PY2024 $101,532.64 81
PY2025 $117,835.30 128

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
BARBARA K BURTON, NPI 1699743088. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1699743088.
APA 7
IndustryPayments. (2026). BARBARA K BURTON, NPI 1699743088 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1699743088
Bluebook
BARBARA K BURTON, NPI 1699743088, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1699743088.

Source: Centers for Medicare & Medicaid Services, Open Payments.